Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $20,720 | 4 | 55.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $10,600 | 7 | 28.4% |
| Travel and Lodging | $3,913 | 15 | 10.5% |
| Food and Beverage | $2,066 | 16 | 5.5% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $56.00 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $12,468 | 15 | $0 (2020) |
| Amgen Inc. | $11,309 | 16 | $0 (2018) |
| Cardinal Health 414, LLC | $11,131 | 4 | $0 (2018) |
| NOVADAQ TECHNOLOGIES INC. | $2,055 | 3 | $0 (2017) |
| Genentech USA, Inc. | $213.30 | 3 | $0 (2018) |
| E.R. Squibb & Sons, L.L.C. | $108.88 | 1 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $69.72 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $178.60 | 2 | E.R. Squibb & Sons, L.L.C. ($108.88) |
| 2020 | $2,840 | 1 | Novartis Pharmaceuticals Corporation ($2,840) |
| 2018 | $18,926 | 17 | Cardinal Health 414, LLC ($11,131) |
| 2017 | $15,411 | 23 | Amgen Inc. ($8,621) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/25/2022 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $69.72 | General |
| Category: ONCOLOGY | ||||||
| 03/09/2022 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $108.88 | General |
| Category: Oncology | ||||||
| 06/13/2020 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Consulting Fee | Cash or cash equivalent | $2,840.00 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2018 | Cardinal Health 414, LLC | Lymphoseek (Drug) | Consulting Fee | Cash or cash equivalent | $9,900.00 | General |
| Category: Hematology Oncology | ||||||
| 12/17/2018 | Cardinal Health 414, LLC | Lymphoseek (Drug) | Travel and Lodging | Cash or cash equivalent | $501.06 | General |
| Category: Hematology Oncology | ||||||
| 10/26/2018 | Cardinal Health 414, LLC | Lymphoseek (Drug) | Food and Beverage | In-kind items and services | $458.84 | General |
| Category: Hematology Oncology | ||||||
| 10/26/2018 | Cardinal Health 414, LLC | Lymphoseek (Drug) | Travel and Lodging | In-kind items and services | $271.00 | General |
| Category: Hematology Oncology | ||||||
| 10/23/2018 | Genentech USA, Inc. | — | Food and Beverage | In-kind items and services | $36.93 | General |
| 05/25/2018 | Amgen Inc. | IMLYGIC (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: Oncology | ||||||
| 04/05/2018 | Amgen Inc. | IMLYGIC (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Oncology | ||||||
| 04/03/2018 | Amgen Inc. | IMLYGIC (Biological) | Food and Beverage | In-kind items and services | $88.35 | General |
| Category: Oncology | ||||||
| 02/24/2018 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Consulting Fee | Cash or cash equivalent | $3,992.00 | General |
| Category: ONCOLOGY | ||||||
| 02/24/2018 | Novartis Pharmaceuticals Corporation | TAFINLAR (Drug), MEKINIST | Travel and Lodging | In-kind items and services | $366.00 | General |
| Category: ONCOLOGY | ||||||
| 02/24/2018 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | In-kind items and services | $253.49 | General |
| Category: ONCOLOGY | ||||||
| 02/24/2018 | Novartis Pharmaceuticals Corporation | SEG101 (Biological) | Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | Cash or cash equivalent | $56.00 | General |
| 02/24/2018 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | In-kind items and services | $54.55 | General |
| Category: ONCOLOGY | ||||||
| 02/24/2018 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | Cash or cash equivalent | $54.00 | General |
| Category: ONCOLOGY | ||||||
| 02/24/2018 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Travel and Lodging | Cash or cash equivalent | $44.18 | General |
| Category: ONCOLOGY | ||||||
| 02/24/2018 | Novartis Pharmaceuticals Corporation | MEKINIST (Drug), TAFINLAR | Food and Beverage | Cash or cash equivalent | $31.42 | General |
| Category: ONCOLOGY | ||||||
| 02/23/2018 | Novartis Pharmaceuticals Corporation | TAFINLAR (Drug), MEKINIST | Travel and Lodging | In-kind items and services | $218.00 | General |
| Category: ONCOLOGY | ||||||
| 12/06/2017 | Amgen Inc. | IMLYGIC (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: Oncology | ||||||
| 12/01/2017 | Amgen Inc. | Neulasta (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $800.00 | General |
| Category: Oncology | ||||||
| 11/15/2017 | Amgen Inc. | IMLYGIC (Biological) | Travel and Lodging | Cash or cash equivalent | $3.96 | General |
| Category: Oncology | ||||||
| 11/01/2017 | Amgen Inc. | IMLYGIC (Biological) | Food and Beverage | In-kind items and services | $95.47 | General |
| Category: Oncology | ||||||
| 09/15/2017 | NOVADAQ TECHNOLOGIES INC. | SPY Technology (Device), PINPOINT, LUNA | Travel and Lodging | Cash or cash equivalent | $812.95 | General |
| Category: Imaging Systems | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 426 | 508 | $236,542 | $48,714 |
| 2022 | 13 | 463 | 542 | $273,246 | $56,835 |
| 2021 | 13 | 479 | 556 | $263,787 | $59,448 |
| 2020 | 10 | 369 | 414 | $143,394 | $32,149 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 92 | $25,932 | $6,727 | 25.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 111 | 137 | $26,257 | $6,576 | 25.0% |
| 38525 | Biopsy or removal of deep lymph nodes of underarm | Facility | 2023 | 19 | 19 | $27,174 | $6,031 | 22.2% |
| 38510 | Biopsy or removal of deep lymph nodes of neck | Facility | 2023 | 15 | 15 | $26,142 | $5,031 | 19.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 40 | $16,584 | $4,575 | 27.6% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2023 | 41 | 41 | $17,427 | $4,367 | 25.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $15,677 | $4,205 | 26.8% |
| 11606 | Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | Facility | 2023 | 19 | 21 | $27,621 | $2,763 | 10.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $9,464 | $2,524 | 26.7% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 28 | 37 | $8,275 | $1,947 | 23.5% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 18 | 24 | $7,741 | $1,627 | 21.0% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Facility | 2023 | 12 | 12 | $15,300 | $1,241 | 8.1% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Facility | 2023 | 11 | 11 | $12,949 | $1,100 | 8.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 70 | 105 | $27,377 | $7,760 | 28.3% |
| 38525 | Biopsy or removal of deep lymph nodes of underarm | Facility | 2022 | 21 | 21 | $31,435 | $7,573 | 24.1% |
| 38510 | Biopsy or removal of deep lymph nodes of neck | Facility | 2022 | 23 | 23 | $40,376 | $7,549 | 18.7% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2022 | 52 | 52 | $22,059 | $5,618 | 25.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 94 | 113 | $19,961 | $5,109 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 50 | 50 | $17,872 | $4,810 | 26.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 26 | 38 | $14,331 | $4,435 | 30.9% |
| 11606 | Removal of cancer skin growth of body, arms, or legs, more than 4.0 cm | Facility | 2022 | 26 | 29 | $36,420 | $4,052 | 11.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 25 | 25 | $12,273 | $3,589 | 29.2% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2022 | 30 | 36 | $8,652 | $1,827 | 21.1% |
| 13121 | Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm | Facility | 2022 | 16 | 16 | $19,326 | $1,658 | 8.6% |
| 13101 | Complicated repair of wound of trunk, 2.6-7.5 cm | Facility | 2022 | 15 | 15 | $16,771 | $1,610 | 9.6% |
About Dr. John Vetto, MD
Dr. John Vetto, MD is a Surgery healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629086103.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Vetto, MD has received a total of $37,355 in payments from pharmaceutical and medical device companies, with $178.60 received in 2022. These payments were reported across 43 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($20,720).
As a Medicare-enrolled provider, Vetto has provided services to 1,737 Medicare beneficiaries, totaling 2,020 services with total Medicare billing of $197,147. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Practice Information
- Specialty Surgery
- Other Specialties Surgical Oncology
- Location Portland, OR
- Active Since 08/03/2006
- Last Updated 03/12/2014
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1629086103
Products in Payments
- Lymphoseek (Drug) $11,131
- IMLYGIC (Biological) $9,709
- MEKINIST (Drug) $7,270
- TAFINLAR (Drug) $5,040
- SPY Technology (Device) $2,055
- Neulasta (Biological) $1,600
- OPDIVO (Biological) $108.88
- LIBTAYO (Biological) $69.72
- SEG101 (Biological) $56.00
- Perjeta (Biological) $52.17
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Portland
Robert Martindale, Md, MD
Surgery — Payments: $1.1M
Dr. Joseph Aferzon, M.d, M.D
Surgery — Payments: $1.0M
Steven Demeester, Md, MD
Surgery — Payments: $906,809
Dr. Sean Orenstein, M.d, M.D
Surgery — Payments: $580,047
Avishai Meyer, Md, MD
Surgery — Payments: $177,013
Vahagn Nikolian, M.d, M.D
Surgery — Payments: $165,208